Form 8-K - Current report:
SEC Accession No. 0001104659-24-024562
Filing Date
2024-02-15
Accepted
2024-02-15 16:42:22
Documents
17
Period of Report
2024-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246433d1_8k.htm   iXBRL 8-K 33313
2 EXHBIIT 10.1 tm246433d1_ex10-1.htm EX-10.1 77749
3 EXHIBIT 10.2 tm246433d1_ex10-2.htm EX-10.2 80993
4 EXHIBIT 10.3 tm246433d1_ex10-3.htm EX-10.3 82095
  Complete submission text file 0001104659-24-024562.txt   511367

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20240210.xsd EX-101.SCH 3015
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20240210_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20240210_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm246433d1_8k_htm.xml XML 3596
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 24644430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)